Filamentous actinomycetes serve as major producers of various natural products including antimicrobial compounds. Although CRISPR-Cas9 systems have been developed for more robust genetic manipulations, concerns of genome instability caused by the DNA double-strand breaks (DSB) and the toxicity of Cas9 remain. To overcome these limitations, here we report development of the DSB-free, singlenucleotide resolution genome editing system CRISPR-BEST (CRISPR-Base Editing SysTem). Specifically targeted by an sgRNA, the cytidine deaminase component of CRISPR-BEST efficiently converts C:G to T:A within a window of approximately seven-nucleotides. The system was validated and successfully used in different Streptomyces species.
tools are called "base editors". A prominent example is the BE3 system for editing human cell lines 11 , which was constructed by artificially fusing the rat APOBEC1 (rAPOBEC1) cytidine deaminase, a Cas9 nickase (Cas9n) and a uracil glycosylase inhibitor (UGI). Localized by the target binding capability of sgRNA/Cas9n, the deamination reaction takes place in the single strand DNA within R-loop of the sgRNA:target DNA complex. The deamination of the targeted C in a C:G base pair results in a U:G mismatch ( Fig. 1a, and 1c ). As U is an illegitimate DNA base, it normally will be recognized and then excised by uracil-DNA glycosylases (UDGs) 12 .
This initiates the conserved nucleotide excision repair (NER) 13 , leading to the reversion to the original C:G base pair. However, this process can be inhibited by UGI.
This triggers the conserved cellular mismatch repair (MMR) 14 to efficiently convert the U:G to a U:A base pair. The efficiency of the MMR repair can be increased by introducing a single-stand DNA nick in proximity to the editing site 11 . Thus, when using BE3 or related systems, the resulting G:U mismatched base pair is retained and converted into an A:T base pair upon Cas9n-mediated nicking of the G-containing DNA strand followed by DNA synthesis. This process generates permanent modifications of the target DNA without the requirement of DSB. By clever selection of the target sites, base editors can thus either generate point mutations resulting in amino acid replacements or the introduction of STOP codons ( Fig. 1e , and Supplementary Table 6 ).
In order to address the limitations of CRISPR-Cas9 in filamentous actinomycetes, here we report development of a DSB-free, single base pair editing system termed as CRISPR-BEST: CRISPR-Base Editing SysTem. As core components, the gene encoding the cytidine deaminase rAPOBEC1 (genbank: NM_012907.2) was codon optimized for Streptomyces and fused to the N-terminus of Cas9n (D10A) using a 16-amino acid flexible linker. In order to inhibit the NER, a Streptomyces codon optimized UGI (genbank accession number: YP_009283008) was fused to the C-terminus of Cas9n by a short linker. sgRNAs can be introduced using a highly effective single strand DNA oligo bridging method. For details, please see Online Methods.
For a proof-of-concept, the actinorhodin biosynthetic gene cluster region of S. coelicolor A3(2) was selected as a target. Potential protospacers containing the editable cytidines were identified in the genes encoded in the target region using the updated CRISPy-web (https://crispy.secondarymetabolites.org), the updates now make the sgRNA identification tool CRISPy-web 15 directly support CRISPR-BEST sgRNA design. In total, twelve protospacers were selected to construct sgRNAs, six targeting the coding strand and six targeting the non-coding strand.
The reported base editors have a less than ten-nucleotide editing window 11, 16 .
Therefore, we investigated all the cytidines within the 10-nucleotides in the PAM-distal region. We observed that not a single cytidine was converted into a thymidine in the first three nucleotides of the hypothetic editing window of all twelve protospacers ( Supplementary Fig. 1 ). Thus, the editing window of CRISPR-BEST can be assigned to seven nucleotides (positions 4 to 10 in the hypothetic editing window) in the PAMdistal region (Fig. 2b ). The cytidines in the editing window were converted into thymidines with frequencies between 30% and 100% ( Supplementary Fig. 1 ). Only in three cases, where the C is preceded by a G, no conversion was observed.
In previous studies it was demonstrated that the rAPOBEC1 based base editor showed different performance when used in vitro compared with in vivo 11 . In order to systematically evaluate the effects of sequence context and the target C position on editing efficiency in a "close to application" context in vivo, we designed a matrix based on the four possible combinations of C with the other three nucleotides, A, T, and G (TCGCACC). In the matrix, the target C of each NC combination was distributed in all seven possible positions ( Fig. 2a ). We used PatScanUI 17 to identify the possible protospacer variants in the genome of S. coelicolor A3(2). Seven protospacers in nonessential genes were selected and tested experimentally ( Fig. 2a ). By calculating the C➔T conversion efficiency (Fig. 2b) , it became obvious that the CRISPR-BEST system is accepting its deamination substrates in the priority of TC>CC>AC>GC ( Fig.   2b ). This finding is consistent with other reports 11, 18 . Within the seven-nucleotide editing window, we observed that positions 2, 3 and 4 showed highest editing efficiency ( Fig. 2b) .
By converting C to T in any of the 64 natural codons, 32 different amino acid substitutions can be generated, which cover almost all 20 natural amino acids ( Fig.   1e ). As an application, Arg codons (CGA), Gln codons (CAA and CAG), and Trp codons (TGG, target C in non-coding strand) are particularly interesting, as they can be converted to stop codons (TGA, TAA, and TAG) by cytidine deamination. For generalizing this strategy, we systematically analyzed the number of potential target sites that lead to STOP codon introduction into the nonessential secondary metabolites biosynthesis genes of the model actinomycete S. coelicolor A3(2) and non-model actinomycete Streptomyces collinus Tü365 using the updated CRISPyweb. An average of about 13 and 14 possible target sites per gene were identified for S. coelicolor A3(2) and S. collinus Tü365, respectively (Supplementary Table 7 and 8). To validate CRISPR-BEST on amino acid substitutions in vivo, two genes, SCO5087 (ActIORF1, KSα of minimal PKS) and SCO5092 (ActVB, dimerase), from the biosynthetic pathway of the diffusible, blue-pigmented polyketide antibiotic actinorhodin in S. coelicolor (Fig. 2c ) were selected. sgRNAs targeting these two genes were designed and cloned into CRISPR-BEST plasmids. Sanger sequencing of the targeted region revealed that all target cytidines were converted to thymidines, ending up with desired amino acid substitutions ( Fig. 2d-2f , Supplementary Fig. 2a and 2b) or introduction of STOP codons ( Fig. 2e and 2f ). The loss-of-function of the gene encoding the actinorhodin polyketide beta-ketoacyl synthase subunit alpha ActIORF1 (SCO5087) completely eliminates actinorhodin biosynthesis ( Fig. 2c ) and thus the dark-blue colored phenotype of the colonies (Fig. 2d ). While ActVB (SCO5092) catalyzes the dimerization of two polyketide precursors as one of the last steps of the actinorhodin biosynthesis, a null mutant ( Fig. 2f ) in this gene leads to the accumulation of the intermediate dihydrokalifungin (DHK) ( Fig. 2c ). Compared to actinorhodin, the colonies exhibit brownish color on ISP2 agar plate ( Fig. 2d ). In all four tested cases, the targeted C were converted to T with an editing efficiency of nearly 100% ( Supplementary Fig. 3 ).
To include a "real world" test example, we next elucidated if CRISPR-BEST is capable of simultaneously inactivating two identical gene copies of the gene kirN (Locus B446_01590 and B446_33700) in the duplicated kirromycin biosynthetic gene clusters (BGCs) 19 of the non-model actinomycete strain S. collinus Tü365 (Fig. 2g ). When using the classical CRISPR/Cas9 system, all clones obtained after pCRISPR-Cas9 treatment targeting kirN completely lost kirromycin production ( Supplementary Fig. 4b ).
Further investigation revealed that the complete loss of kirromycin production and unsuccessful complementation with plasmid-encoded kirN was due to large deletions of both chromosome arms (787,795 bp from the left arm, 630,478 bp from the right arm), which contain the two copies of the kirromycin BGC ( Fig. 2h ). These deletions were likely caused by the simultaneous DSBs introduced by Cas9.
For CRISPR-BEST, a protospacer within kirN was identified that should introduce an early STOP codon ( Fig. 2i ). After transferring the CRISPR-BEST plasmid with the kirN-targeting sgRNA into S. collinus Tü365, sequencing of PCR products of the target region demonstrated that the cytidines were converted to thymidines and thus a STOP codon was successfully incorporated into kirN (Fig. 2j ). In production assays using the kirNW135àSTOP mutant, kirromycin was still produced but with a much lower yield compared to the wild-type strain (WT) ( Supplementary Fig. 4a , 4c-4e), which is consistent with our previous observation of the mutant that was generated by classic homologous recombination-based gene knockout approach 20 .
The above examples clearly demonstrate the potential of CRISPR-BEST in efficiently introducing mutations in the actinomycetes genome without involving DSBs, resulting in reduced risk of genome instability often caused by CRISPR-Cas9. A comprehensive comparison of CRISPR-BEST with CRISPR-(d)Cas9 or classical actinomycete mutagenesis approaches is included in Supplementary Table 1 . Taken together, CRISPR-BEST is a powerful addition to the actinomycete CRISPR-Cas9-based genome editing toolbox.
Methods

Strains, plasmids, and culture conditions
The strains and plasmids used in this study are listed in Supplementary Table 2 . All plasmids were maintained in E. coli DH5alpha. All E. coli strains and Bacillus subtilis 168 were grown in LB medium (agar and liquid) at 37°C. Streptomyces strains were grown at 30 °C in either ISP2 (Yeast extract 4 g/l, Malt extract 10 g/l, Dextrose 4 g/l, 20 g/l Agar is added for solidification) for seed culture and DNA preparation, or in MS-MgCl2 (20 g/l each D-mannitol, soya flour, agar, and 10mM MgCl2) for sporulation and conjugation. Kirromycin production medium (10 g/l full-fat soy flour, 10 g/l D-mannitol, and 5 g/l CaCO3, dissolved in tap water and pH adjusted to 7.4 prior to autoclaving) was used for kirromycin production assays. Appropriate antibiotics were supplemented as necessary (50 µg/ml apramycin; 50 µg/ml nalidixic acid; 0.5 µg/ml thiostrepton; 25 µg/ml kanamycin; and 25 µg/ml chloramphenicol). E. coli ET12567/pUZ8002 was used for conjugating plasmids into streptomycetes as described previously 2 .
Construction of CRISPR-BEST plasmids
All primers used in this study are listed in Supplementary Table 3 .
A self-replicating pSG5-based thermosensitive E.coli-Streptomyces shuttle vector pGM1190 21 (Fig. 1b ) was used as the backbone plasmid to construct the CRISPR-BEST plasmid. The sgRNA cassette design is similar to our previous pCRISPR-Cas9 system 22 . In order to simplify the 20nt-spacer cloning process and increase its cloning efficiency, we modified the original sgRNA cassette to be compatible with single strand DNA (ssDNA) oligo bridging method (lower-middle panel of Fig. 1d ) by removal of a G from the pGM1190-sgRNA 22 which is been depositing to Addgene.
Single-strand DNA based PCR-free spacer cloning protocol
To use the pCRISPR-BEST for base editing applications, only one step is required, which is the insertion of a 20nt spacer into the sgRNA scaffold. A ssDNA oligo based, PCR-free method was adopted for spacer cloning in this study. The oligo was designed as CGGTTGGTAGGATCGACGGCN20GTTTTAGAGCTAGAAATAGA. As designed, the pCRISPR-BEST plasmid can be linearized by NcoI. By mixing the linearized pCRISPR-BEST plasmid and chemically synthesized spacer containing oligo with the NEBuilder (New England Biolabs, USA). The linearized pCRISPR-BEST plasmid then will be bridged by the spacer containing oligo, ending up with the desired pCRISPR-BEST. Mach1™-T1 R E. coli (Life Technologies, UK) was used for cloning.
Because of the high bridging efficiency, 4-8 clones were directly sanger sequenced using primer "stre_spacer_seq" to screen for the correct constructs. All plasmids generated and used were listed in Supplementary Table 2 .
In vivo spacer-matrix design using PatScan
As two key components of this spacer-matrix are the positions and the variants of TCGCACC in the 23nt protospacer plus PAM sequence. The pattern of the matrix is N2-3(TCnGCnACnCn)N12-11GG, where n = 1 to 7, therefore, the matrix contains in total seven pieces of protospacer ( Fig. 2a and Supplementary Table 4 ). PatScanUI 17 (https://patscan.secondarymetabolites.org) was used to locate all possible protospacers in the genome of S. coelicolor A3(2). Each found protospacer was crosscompared with all spacers of S. coelicolor found by CRISPy-web 15 , then the ones with less off-target effects were manually checked if they are inside of essential genes or not, based on the genome annotation of S. coelicolor A3(2). The rules for matrix protospacer selection are: not in essential gene; not located too close to the chromosome end; less off-target effects; and if possible, select the ones sharing the same PAM sequence.
CRISPR-BEST support in CRISPy-web
For the updated CRISPy-web, sgRNAs are identified using the regular CRISPy-web algorithm published previously 15 
CRISPR-BEST compatible protospacers identification using CRISPy-web
The procedure is based on our previous report 15 . Briefly, a custom genome or an antiSMASH generated job id needs to be uploaded to CRISPy-web (https://crispy.secondarymetabolites.org). Taking kirN of S. collinus Tü365 as an example ( Supplementary Fig. 7a ), all possible protospacers from both DNA strands will be displayed for the kirN gene ( Supplementary Fig. 7b ). By choosing the "Show CRISPR-BEST output" box, all CRISPR-BEST compatible protospacers will be displayed ( Supplementary Fig. 7c) , showing the possible amino acid substitutions. By subsequentially choosing the "Show only STOP mutations" box, all possible STOP codon introductions will be displayed ( Supplementary Fig. 7d ), and the selected protospacers can be downloaded as CSV file by clicking the shopping basket located in the up-right corner.
In-frame deletion of kirN using CRISPR-Cas9 based homologous recombination strategy
The in-frame deletion of kirN in S. collinus Tü365 using CRISPR-Cas9 based homologous recombination approach was carried out as we described in 23 . USER cloning approach was used for the plasmid assembly 23 . The 20nt spacer region GATCGCATTTCGCCAACTAC that specifically targeted on kirN was predicted CRISPy-web 15 (https://crispy.secondarymetabolites.org). The 462 bp sgRNA-kirN cassette was ordered as a gBlocks® Gene Fragment from IDT (Integrated DNA Technologies, US) and the full sequence can be found in Supplementary Table 5 . The directional assembly of the sgRNA and the two 1kb editing templates, interspaced by the ermE* promoter, in the linearized pCRISPR-USER-Cas9 was ensured by the uracil-containing overhangs generated by PCR amplification with primer pair pHR1/pHR2 for the sgRNA gBlocks® gene fragment, pHR3/pHR4 for the ermE* promoter, and primer pairs pHR5/pHR6 and pHR7/pHR8 for the 1kb editing templates up-and down-stream of kirN, respectively. The 1 kb editing templates were amplified from genomic DNA of S. collinus Tü365.
Upon the USER assembly, correct clones of pCRISPR-∆kirN were identified with control PCR with pHR9/pHR10 and confirmed by Sanger sequencing with primers pHR9 and pHR13. The resulting pCRISPR-∆kirN was introduced into S. collinus Tü365 by intergeneric conjugation following a protocol reported previously 2 .
Base pair changes were evaluated by Sanger sequencing
First, primers that can amplify a several-hundred base pairs region containing the base editing window were designed ( Supplementary Table 3 ). Secondly, colony PCR approach was used to amplify the designed regions directly from streptomycetes colonies. The protocol was modified from our previous publication 22 : about foursquare-millimeter actively growing mycelia (for example, 3-day old S. coelicolor, before sporulation) of the selected colonies were scraped from the agar plate using a sterile toothpick into 20 μl pure DMSO in PCR tubes. The tubes were shaken and boiled vigorously for 20 min at 100 °C in a heating block. After cooling down to room temperature, the solution was centrifuged at top speed for 30 seconds, 1 μl of the supernatant was used as the PCR template in a 20 μl-reaction with Q5 High-Fidelity DNA Polymerase (New England Biolabs, US). Lastly, the PCR products were cleaned up by kits from Thermo Fisher Scientific, USA and then sanger sequenced by Mix2Seq kit (Eurofins Genomics, Germany).
Kirromycin fermentation and analysis
The protocol was modified from 20 . Four-day old seed cultures (grown in ISP2), normalized according to wet weight, were inoculated into kirromycin production medium ending up with in total 50 ml in shake flasks. The fermentations were carried out for six days at 30°C in a rotary shaker at 180 rpm. 30 ml of each culture was extracted with 1:1 ethyl acetate for 2 h at room temperature. The extracts were then dried, re-dissolved in 200 μl methanol, and stored in -20°C for further applications. 
Bioactivtivity assay of kirromycin
Wild type Bacillus subtilis was used as indicator strain. An overnight B. subtilis colony of approximately four-square-millimeter was transferred from LB agar plate into 1 ml LB liquid medium in a 1.5 ml Eppendorf tube. The suspension was mixed by vortexing.
200 µl of the above suspension was plated onto a LB agar plate, air drying for 5 min inside of a clean bench. Sterilized paper disks were placed onto the same LB agar plate, then 20 µl of each exact was added onto the paper disks. The resulting LB plate was incubated at 37°C incubator for 24 h, the image was taken by a ColonyDoc-It™ Imaging Station (Analytik Jena AG, Germany).
Assay for actinorhodin extraction
Exconjugants were picked and streaked onto apramycin containing ISP2 agar plate and incubated for five days at 30 °C. The photos of related plates were taken by a ColonyDoc-It™ Imaging Station (Analytik Jena AG, Germany). Actinorhodin extraction assay was carried as following procedural: 10 ml of seven days old S. coelicolor ISP2 culture was mixed 1:1 with 1 N NaOH. Extracting for 4 h using a magnetic stirrer at room temperature. The suspensions were centrifuged at 10,000 g for 5 min, the supernatants were transferred into PCR tubes. All tubes were placed under the same filed for photo taken by a ColonyDoc-It™ Imaging Station (Analytik Jena AG, Germany), so that their color could be directly compared.
DNA manipulation
All primers and spacers used in this work are listed in Supplementary Table 3 and Supplementary 
Illumina whole genome sequencing and analysis
Illumina sequencing was carried out as we described before 22 . Briefly, a 10 ml five days old S. collinus cluture was used for genomic DNA isolation. The genomic library was generated using the TruSeq ®Nano DNA LT Sample Preparation Kit (Illumina Inc., US). The reads obtained from the Illumina sequencing were mapped to the WT S.
collinus Tü365 reference genome (NCBI accession: CP006259) using the software BWA with the BWA-mem algorithm. The data was inspected and visualized using readXplorer and Artemis. 
